Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucoidan Therapy in Adults With Active Rheumatoid Arthritis
NCT07045896Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Polysaccharide, Nutraceutical
- Countries
- 1
01
Overview
A Phase 2 trial of fucoidan in rheumatoid arthritis (RA), sponsored by Peking University People's Hospital. Started Jan 2026; status: recruiting.
02
Drugs
fucoidan
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07045896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045896.